Cognitive Training for Digital Biomarkers

Sponsor
Taipei Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06090942
Collaborator
(none)
90
2
9.4

Study Details

Study Description

Brief Summary

This study aims to conduct cognitive training for digital biomarkers among older adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Smartphone-based cognitive training
N/A

Detailed Description

The prevalence of dementia in rural areas is higher than in urban areas. However, the resource and research input on cognitive training for rural older adults still needs improvement. There is also no solution for preventing or early detection of dementia in rural areas. Unlike biomarkers that require invasive detection, digital biomarkers have been advocated in recent years for early disease prediction. However, there are still few studies on the effectiveness of digital biomarkers in evaluating cognitive function in the elderly. In addition, although previous studies have confirmed that cognitive training can be effective for older adults, it is difficult for the elderly in rural areas to obtain these cognitive-promoting resources due to distance. Moreover, the autonomy and right of choice of older adults are the keys to the success of their health behavior change.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
The Effectiveness of Cognitive Training for Digital Biomarkers: Evidence From the Urban and Rural Area
Anticipated Study Start Date :
Oct 20, 2023
Anticipated Primary Completion Date :
Jul 31, 2024
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive training

Smartphone-based cognitive training

Other: Smartphone-based cognitive training
Smartphone-based cognitive training

No Intervention: Usual care

No intervention

Outcome Measures

Primary Outcome Measures

  1. digital biomarker [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    wearable device of stress and sleep, EEG power in alpha band, Delta and Theta frequency-bands

Secondary Outcome Measures

  1. Montreal Cognitive Assessment(MoCA) [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    The Montreal Cognitive Assessment (MoCA) is a cognitive screening tool designed to identify mild cognitive impairment, providing a quick assessment of different cognitive domains including memory, attention, language, and executive functions. It is widely utilized in clinical and research settings.The MoCA is scored out of a maximum of 30 points. A score of 26 and above is generally considered to be normal, although the specific cutoff can depend on the individual's age, educational level, and other demographic factors.

  2. Digit Span(DS) [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    Digit Span (DS) is a common test used in neuropsychological assessments to measure working memory, attention, and concentration. Each correctly repeated sequence yields one point. There are typically 16 items for the Forward Digit Span. The Backward Digit Span also has 16 items.

  3. Digit Vigilance Test(DVT) [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    The Digit Vigilance Test (DVT) is a psychological assessment tool used to measure attention and concentration, mainly focused on visual scanning and processing speed. The number of correct identifications and the time taken to complete the task are typically measured.

  4. Computerized version of Wisconsin Card Sort Test (WCST) [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    The Wisconsin Card Sorting Test (WCST) is a well-established neuropsychological test widely used to assess executive functions, mainly focusing on abstract reasoning and the ability to shift cognitive strategies in response to changing environmental contingencies (i.e., set-shifting or cognitive flexibility). The computerized version of the WCST allows for efficient, standardized administration and scoring, often reducing examiner bias and error.

  5. Stroop color-word test (SCWT) [pretest, immediate post test, 3 month follow-up, 6 month follow-up]

    The Stroop Color-Word Test (SCWT) evaluates cognitive processing speed, selective attention, and cognitive flexibility, which are aspects of executive functioning. It's particularly notable for its ability to detect cognitive interference and inhibition control.Scores are typically based on:Correct Responses, Time Taken, Error Rate and Interference Score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. At least 60 years of age, Can communicate in Chinese (Taiwanese)

  2. Bring your own mobile device with Internet access.

  3. Can act alone without physical impairment;full score of basic activities of daily living scale and instrumental activities of daily living scale.

Exclusion Criteria:
  1. Dementia diagnosed by a physician and in compliance with ICD-10

  2. Physician diagnosed with significant mental illness or communication impairment

  3. Participated in other cognitive training studies within the past year

  4. Medical conditions associated with rapid functional and cognitive decline

  5. Severe visual impairment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Taipei Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Huie-Ling Chiu, Associate professor, Taipei Medical University
ClinicalTrials.gov Identifier:
NCT06090942
Other Study ID Numbers:
  • N202303103
First Posted:
Oct 19, 2023
Last Update Posted:
Oct 19, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Huie-Ling Chiu, Associate professor, Taipei Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2023